腔内注射得力生治疗肺癌恶性胸腔积液

Clinical effect study of Delisheng treatment in lung cancer patients with malignant pleural effusion

目的研究得力生注射液治疗肺癌恶性胸腔积液的疗效。方法对38例恶性胸腔积液患者行胸腔置管引流胸水后注入得力生注射液50￣60mL,每周2次。结果完全缓解(CR)13例,部分缓解(PR)20例,有效率(CR+PR)86.8%。主要不良反应为轻度胸痛。结论得力生注射液治疗肺癌恶性胸腔积液安全有效,值得进一步研究。

[ objective ] To study the clinical effects of Delisheng treatment through intrapleural instillation in lung cancer patients with malignant pleural effusion. [Methods] 38 cases of lung cancer patients with malignant pleural effusion were treated by intrapleural instillation Delisheng injection 50-60 mL after pleural effusion was drawn, twice per week. [Results] The effective rate （CR＋PR） was 86.8%, The main side effect was chest pain. [Conclusion] Delisheng injection treatment in lung cancer patients with malignant pleural effusion was safe and effective, It is worth further study.